about
A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.The quest for an antibody-based HIV vaccine.cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.Conserved HIV Epitopes for an Effective HIV Vaccine.Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Polyvalent vaccine approaches to combat HIV-1 diversity
@en
Polyvalent vaccine approaches to combat HIV-1 diversity.
@nl
type
label
Polyvalent vaccine approaches to combat HIV-1 diversity
@en
Polyvalent vaccine approaches to combat HIV-1 diversity.
@nl
prefLabel
Polyvalent vaccine approaches to combat HIV-1 diversity
@en
Polyvalent vaccine approaches to combat HIV-1 diversity.
@nl
P2860
P50
P921
P356
P1476
Polyvalent vaccine approaches to combat HIV-1 diversity
@en
P2093
Kshitij Wagh
P2860
P304
P356
10.1111/IMR.12516
P5008
P577
2017-01-01T00:00:00Z